3',5'-O-bis(tert-butoxycarbonyl)gemcitabine

Names

[ CAS No. ]:
250698-52-3

[ Name ]:
3',5'-O-bis(tert-butoxycarbonyl)gemcitabine

[Synonym ]:
3',5'-di-O-t-butoxycarbonyl-2',2'- difluoro-2'-deoxycytidine
3',5'-O-bis-(tert-butoxycarbonyl)gemcitabine
3',5'-di-BOC-gemcitabine
3',5'-bis-O-tert-butoxycarbonyl gemcitabine

Chemical & Physical Properties

[ Molecular Formula ]:
C19H27F2N3O8

[ Molecular Weight ]:
463.43000

[ Exact Mass ]:
463.17700

[ PSA ]:
141.20000

[ LogP ]:
3.21140


Related Compounds

  • 3',5'-O-bis(tert-butyldimethylsilyl)-5-([D3]methyl)-2'-deoxycytidine
  • 3',5'-O-bis(tert-butyldimethylsilyl)-2-N-phenoxyacetyldeoxyguanosine
  • 3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxy-5-methylcytidine
  • 5-(4-benzoylthiobut-1-ynyl)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyuridine
  • 2',3'-Di-O-(tert-butyldimethylsilyl)-2'-deoxycytidine
  • 3',5'-O-bis-(trimethylsilyl)-2'-deoxyuridine
  • 2,6-dimethyl-4-(1-methyl-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)morpholine
  • (3,4-Dimethylphenyl)[1-methyl-6-(prop-2-enylamino)pyrazolo[4,5-e]pyrimidin-4-y l]amine
  • N~6~-benzyl-N~4~-(3,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
  • N~4~-(3,4-dimethylphenyl)-1-methyl-N~6~-(4-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
  • N-(3,4-dimethylphenyl)-1-methyl-6-(pyrrolidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 6-[4-(3-chlorophenyl)piperazin-1-yl]-N-(3,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • N~4~-(4-methoxyphenyl)-1-methyl-N~6~-(2-phenylethyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
  • 3-({4-[(4-methoxyphenyl)amino]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl}amino)propan-1-ol
  • 6-[4-(4-fluorophenyl)piperazin-1-yl]-N-(4-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.